Conference · Berlin, Germany
Biosimilars Conference 2014
Health · Medicine
Key numbers
- Editions on record
- 2first in 2014
About Biosimilars Conference
Biosimilars 11th Annual Conference: Identify and execute a successful biosimilar development plan with technical case studies and practical advice from leading biosimilar and regulatory players
Key reasons not to miss Biosimilars 2014:
• Hospira and Egis Pharmaceuticals discuss the routes and launch strategy for the very first mAb biosimilar in Europe - how should you spend your resources?
• Discover the latest on EU positions for interchangeability and substitution and comparison with the FDA proposals
• Learn from Teva on how to carry out meaningful “fingerprint”-like analysis for effective biosimilar characterisation
• Benchmark your global clinical biosimilar trials – experience from Sandoz examples with TNFα inhibitors.
• Understand global development of biosimilars: with insight into Russia, CIS, Latin America and China
Speakers Include:
Dr. Gabriele Reichmann - Paul-Ehrlich-Institute
Paul Greenland Hospira - Biologics Hospira
Dr Virginia Acha - Amgen
Dr Karsten Roth Sandoz - Sandoz Biopharmaceutical Development
Peter Mazsar MD - Egis Pharmaceuticals
Henri Kornmann - Merck Serono
Fermin Ruiz de Erenchun - Roche
Daotian Fu Livzon - Mabpharm, Inc.
and many more...
From our listing of this edition. Details may have changed since.
Editions
| Year | Dates | Where | Exhibitors | Visitors |
|---|---|---|---|---|
| 2015 | 18–20 May 2015 | Maritim proArte Hotel Berlin Berlin, Germany | — | — |
| 2014 | 21–22 May 2014 | Leonardo Royal Hotel Berlin, Germany | — | — |
Past editions from the bvents archive (2008–2019) and organiser figures where they were published.